Abstract:Disulfiram (DSF), a U.S. Food and Drug Administration (FDA)-approved drug for the treatment of chronic alcoholism, is also used as an antitumor drug in combination with Cu2+ ions. However, studies have shown that the endogenous Cu2+ dose in tumor tissues is still insufficient to form relatively high levels of a bis(N,N-diethyldithiocarbamate) copper(II) complex (denoted as Cu(DTC)2) to selectively eradicate cancer cells. Here, DSF-loaded hollow copper sulfide nanoparticles () were designed to achieve tumor microenvironment (TME)-activated in situ formation of cytotoxic Cu(DTC)2 for NIR-II-induced, photonic hyperthermia-enhanced, and DSF-initiated cancer chemotherapy. The acidic TME triggered the gradual degradation of , promoting the rapid release of DSF and Cu2+ ions, causing the in situ formation of cytotoxic Cu(DTC)2, to achieve efficient DSF-based chemotherapy. Additionally, exhibited a notably high photothermal conversion efficiency of 23.8% at the second near-infrared (NIR-II) biowindow, thus significantly inducing photonic hyperthermia to eliminate cancer cells. Both in vitro and in vivo studies confirmed the effective photonic hyperthermia-induced chemotherapeutic efficacy of DSF by integrating the in situ formation of toxic Cu(DTC)2 complexes and evident temperature elevation upon NIR-II laser irradiation. Thus, this study represents a distinctive paradigm of in situ Cu2+ chelation-initiated "nontoxicity-to-toxicity" transformation for photonic hyperthermia-augmented DSF-based cancer chemotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c08848?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c08848</a>.Size distribution, zeta potential, FTIR spectra, extinction coefficient, photothermal performance, accumulative releasing performance, cell viability, intracellular internalization, cellular apoptosis, mRNA expression, body weight, blood parameters, and H&E staining (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c08848/suppl_file/nn0c08848_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Terbium-triggered Aggregation-Induced Emission of Bimetallic Nanoclusters for Anticancer Drugs Sensing Via the Inner Filter Effect.

Ternary Z-Scheme Ag-Embedded TiO2-Ag2S Nanojunction As a Novel Photoelectrochemical Converter for CD44 Detection

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

A dual-emitting Tb(iii)&Yb(iii)-functionalized coordination polymer: a "turn-on" sensor for N-methylformamide in urine and a "turn-off" sensor for methylglyoxal in serum.

Smart Cancer-Targeting and Super-Sensitive Sensing of Eu3+/Tb3+-Induced Hyaluronan Characteristic Nano-Micelles with Effective Drug Loading and Release

Ph and Glutathione Synergistically Triggered Release and Self-Assembly of Au Nanospheres for Tumor Theranostics.

Lanthanide (Eu3+/Tb3+)-Loaded γ-Cyclodextrin Nano-Aggregates for Smart Sensing of the Anticancer Drug Irinotecan

A Turn-ON fluorometric biosensor based on ssDNA immobilized with a metal phenolic nanomaterial for the sequential detection of Pb(ii) and epirubicin cancer drug

Serum levels of IGFBP-3: usefulness in diagnosis of GH deficiency and relationship to measurements of GH secretion in children.

Structure regulation for ultra-high luminescence quantum yield lanthanide complex and simultaneous detection of cancer marker and ferrous ion

Metal ions-bridged J-aggregation mediated nanoassembly composition for breast cancer phototherapy

Tetraphenylethene-Based Highly Emissive Metallacage As A Component of Theranostic Supramolecular Nanoparticles

Ratiometric Detection of Zn2+ and Cd2+ Based on Self-Assembled Nanoarchitectures with Dual Emissions Involving Aggregation Enhanced Emission (AEE) and Its Application

Preparation of Metal Nanocluster Supraparticles for Ultrasensitive Sensing of Tetracycline Based on Multiple Interactions Between a Target and Sensor.

Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow

Highly Sensitive Identification of Cancer Cells by Combining the New Tetrathiafulvalene Derivative with a Β-Cyclodextrin/multi-walled Carbon Nanotubes Modified GCE

Selective decontamination of the digestive tract and prevention of ventilator-associated pneumonia.

A Tumor Microenvironment-Responsive Theranostic Agent for Synergetic Therapy of Disulfiram-Based Chemotherapy and Chemodynamic Therapy.

A novel fluorescent nanoprobe for sensitive detection of 6-thioguanine in human serum based on Cu/Ag nanoclusters

Tumor-targetable magnetoluminescent silica nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo

Highly Efficient GSH-Responsive “Off–On” NIR-II Fluorescent Fenton Nanocatalyst for Multimodal Imaging-Guided Photothermal/Chemodynamic Synergistic Cancer Therapy